Morabito Christopher
Officer at Astria Therapeutics, Inc.
- Sold, on record
- $247k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Apr 1, 2024
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Astria Therapeutics, Inc.Officer
Sales by reason
2
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, every sale on record.
Timeline
- 1 Form 144 notice Astria Therapeutics, Inc.NoticeJan 29, 2024 2024
Filed to sell 9,200 shares ($103k)
Morabito Christopher, Officer
10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale Astria Therapeutics, Inc.RoutineJan 29, 2024 same day
Sold 10,000 shares at $11.14 ($111k)
Morabito Christopher, Chief Medical Officer
10b5-1 planSold 100% of holdings ($111k position)0 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice Astria Therapeutics, Inc.NoticeApr 1, 2024 +63 days
Filed to sell 10,000 shares ($136k)
Morabito Christopher, Officer
10b5-1 planFiling
- 4 Form 4 sale Astria Therapeutics, Inc.RoutineApr 1, 2024 same day
Sold 10,000 shares at $13.59 ($136k)
Morabito Christopher, Chief Medical Officer
10b5-1 planSold 100% of holdings ($136k position)0 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2024 | Apr 3, 2024 | Astria Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 10,000 | $136k | 100.0% | Routine | SEC |
| Apr 1, 2024 | Apr 1, 2024 | Astria Therapeutics, Inc. | Officer | Form 144 notice | 10,000 | $136k | Notice | SEC | |
| Jan 29, 2024 | Jan 30, 2024 | Astria Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 10,000 | $111k | 100.0% | Routine | SEC |
| Jan 29, 2024 | Jan 29, 2024 | Astria Therapeutics, Inc. | Officer | Form 144 notice | 9,200 | $103k | Notice | SEC |